comparemela.com
  1. Home
  2. Live Updates
  3. Xphyto - Breaking News

Latest Breaking News On - Xphyto - Page 4 : comparemela.com

XPhyto Therapeutics Corp : XPhyto Closes First Tranche of Financing

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that further to its

United statesBaden wübergBritish columbiaHugh rogersXphyto therapeutics corpNorth americaMarket regulator

XPhyto Therapeutics Corp : XPhyto Provides Progress Update on Psychedelic Medicine Programs and Novel Compounds Milestone

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 22, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide an update on its wholly

United statesBaden wübergBritish columbiaHugh rogersKnox hendersonXphyto therapeutics corpUniversity of albertaXphyto laboratories incInnovation centreXphyto labDrug developmentApplied pharmaceutical innovationSan pedroNorth americaMarket regulator

XPhyto Therapeutics Corp : XPhyto Reports on its Three Primary Business Divisions

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 8, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report on its three business

United statesBaden wübergBritish columbiaVektor pharmaI vektor pharmaHugh rogersKnox hendersonGmbh vektor pharmaXphyto therapeutics corpXphyto laboratories incLaboratories incNorth americaMarket regulator

XPhyto Therapeutics Corp : XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as Part of Multi-Product Rollout Strategy

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 1, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the execution of Covid-ID

United statesBaden wübergBritish columbiaHugh rogersKnox hendersonCorona testzentrenRoland spleissXphyto therapeutics corpBusiness developmentNorth americaMarket regulator

XPhyto Therapeutics Corp : XPhyto Announces Head of Sales, Europe

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 17, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of

United statesBaden wübergBritish columbiaDrahoslav zdarekHugh rogersKnox hendersonPharma gmbHeinrich jehleRoland spleissThomas beckertTeva pharmaceuticalCompany german ce markHead of diagnostic researchXphyto therapeutics corpCompany head of salesEuropean union

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.